IMPACT OF BREATH CONTROL AND RETENTION ON PATIENT STRESS. E.S IN MEDICALLY ASSISTED REPRODUCTION
NCT ID: NCT06357208
Last Updated: 2024-10-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2024-05-06
2024-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Conservative Treatments for Urinary Incontinence in Women
NCT05977231
Effect of Exercise and Biofeedback on Symptoms of Incontinence in Women With Stress Urinary Incontinence
NCT01337193
A Study of the Use of Vaginal Radiofrequency Therapy in Treatment of SUI.
NCT05570071
Exercise During Pregnancy and Urinary Incontinence
NCT03997045
Outpatient Biofeedback in Addition to Home Pelvic Floor Muscle Exercises
NCT02851719
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
During this exchange, the psychologist gives him the evaluation scales, explains to him when to complete them and re-explains the progress of the study.
Patients in the active "Breathing Control and Retention" group make 4 appointments, one week apart, with the Bluenery Academy. The participants self-assess 2 days before starting the breathing program (M0), 2 days after the end of the program, 1 month after starting the program (M1).
Patients in the "Usual follow-up" control group complete the self-assessments 2 days after the discussion with the psychologist (M0) and 1 month later (M1).
At the end of the 2 assessments, the patient was included. sends his assessment book to the psychologist.
An appointment will be made after the rating to communicate the results to them.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Breathing Control and Retention
Breathing Control and Retention
Breathing Control and Retention
4 appointments with training of Breathing Control and Retention
Usual follow-up
the patient come at the begin of the study and come back after one month
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Breathing Control and Retention
4 appointments with training of Breathing Control and Retention
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* couple with medical infertility defined as absence of pregnancy after 12 months without contraception,
* age greater than 18 years,
* patient who has signed informed consent and affiliated to social security.
* Patient available at the proposed slots over 4 weeks
Exclusion Criteria
* heart failure
* Thrombocytopenia
* epilepsy
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nice
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Valérie BENOIT
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Universitaire de Nice
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chu de Nice
Nice, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-A02687-38
Identifier Type: OTHER
Identifier Source: secondary_id
23-AOI-06
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.